Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy

Rami Younan, Shigeki Kusamura, Dario Baratti, Alexis Simon Cloutier, Marcello Deraco

Research output: Contribution to journalArticle

Abstract

To reach a consensus for reporting complications related to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Reporting the adverse events related to CRS + HIPEC is not standardized yet. Post-operative complications can be divided in two categories: the effects of surgical manipulation per se and the toxic effects of the heated intraoperative chemotherapy. Additive and/or synergistic effects also exist. Different centers have published their experience with regard to the complications associated with the procedure. Various classification systems have been used which makes a temptative comparison of the different techniques and results almost impossible. An effort was made here to review the existing major classification systems: The Bozzetti classification, the Clavien classification (and two proposed modifications from Feldman et al. and Elias et al.) and the Common terminology criteria for adverse events (CTCAE) version 3.0 of the National Institute of Health (NIH) criteria. A related document was sent to an international panel of experts. The CTCAE was adopted by the panel of experts as the unique classification system to be used for reporting complications related to CRS + HIPEC.

Original languageEnglish
Pages (from-to)253-257
Number of pages5
JournalJournal of Surgical Oncology
Volume98
Issue number4
DOIs
Publication statusPublished - Sep 15 2008

    Fingerprint

Keywords

  • Cytoreductive surgery
  • HIPEC
  • Intraperitoneal chemotherapy
  • Morbidity
  • Peritoneal surface malignancy
  • Toxicity

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this